HEIDI PATTAROZZI: Open Payments
NPI 1649528621 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,407 in 84 payments from 10 companies in 2025. Trend: 2023 $1,055 · 2024 $1,681 · 2025 $1,407
Food & beverage: $1,407
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 18 | $356 |
| Otsuka America Pharmaceutical, Inc. | 23 | $238 |
| ABBVIE INC. | 15 | $207 |
| Neurocrine BioSciences, Inc. | 7 | $162 |
| E.R. Squibb & Sons, L.L.C. | 6 | $130 |
| Teva Pharmaceuticals USA, Inc. | 5 | $100 |
| Alkermes, Inc. | 5 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Lundbeck LLC | 1 | $19 |
Products named: FANAPT, VRAYLAR, REXULTI, INGREZZA, COBENFY, ARISTADA, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across NM — which companies pay providers there.
